This toolkit introduces the ASAM criteria, a framework for organizing addiction treatment systems and a foundation for improving the quality of care and addressing the gap between the efficacy of treatment in clinical trials and effectiveness in real world settings. By rooting substance use disorder (SUD) services in a common framework such as the ASAM criteria, states can ensure that organizations are "speaking the same language" when it comes to SUD prevention and treatment.  

This is a report which describes lessons learned from states that acted as models for statewide approaches that prevent and address adverse childhood experiences and development of trauma-informed policies. The report also highlights the goals, policies, and programs developed and launched by states that were selected for the project. 

This report published by the National Academy for State Health Policy (NASHP) gives an overview on the connection between opioid use disorder and neonatal abstinence syndrome (NAS). The report also highlights state approaches to NAS data collection, analysis, and cross-agency data linkage, and how states leverage these data to inform better policy and improve health outcomes for both parents and infants. 

This is a report from the CDC that identifies state strategies to improve outcomes for pregnant and postpartum women with opioid use disorder and infants prenatally exposed to substances, including opioids. It discusses strategies focused on access to and coordination of quality services, including approaches such as telemedicine that are useful in rural areas. In addition, there is discussion of strategies related to provider awareness and training among other topics.

This is a report from the National Academy for State Health Policy (NASHP) that discusses how child-serving agencies are responding to the opioid crisis. It includes states’ strategies to support young children and families impacted by opioid use disorder (OUD), available state and federal funding sources for these initiatives, and key considerations for states working to improve services and outcomes for this vulnerable population. 

This is a toolkit by the American Hospital Association (AHA) that provides resources to hospitals and health systems to share with clinicians and patients to enhance partnerships within their communities. It also highlights several innovative programs with links to them.  

This study develops a typology of the stigma related to opioid use, showing how multiple dimensions of stigma continue to fundamentally hinder the response to the crisis.

The paper explains how public stigma is driven by stereotypes about people with opioid use disorders, such as their perceived dangerousness or perceived moral failings, which translate into negative attitudes toward people with opioid use disorders. Additionally, it explains that enacted stigma describes the behavioral manifestations of public stigma, including discrimination and social distancing. Finally, the study emphasizes that public and enacted stigma, in turn, lead to the delivery of suboptimal care and undermine access to treatment and harm reduction services.

This in an annual summit sponsored by National Academy of Medicine and Shatterproof that brings together stakeholders to discuss the negative impact of stigma on people with substance use disorders and elevate action-oriented strategies to address and eliminate the harms caused by stigma. More information from the 2021 summit can be found here and the 2022 summit can be found here. 

The Rockefeller Institute's Stories from Sullivan series combines aggregate data analysis with on-the-ground research in affected communities to provide insight into what the opioid problem looks like in this rural county, how the community has responded, and what kinds of policies have the best chances of making a difference. 

This paper describes the strategies and policies implemented in Ohio to improve opioid safety and discusses the role that pharmacists can play in implementing, promoting, and enhancing the effectiveness of these policies. In particular, the Governor's Cabinet Opiate Action Team is discussed, which created and implemented a multifaceted strategy which significant reduced opioid prescribing the state. 

This is a report from the Deloitte Center for Health Solutions on how data analytics can help health plans and pharmacy benefit managers (PBM) combat the opioid crisis by improving prevention and treatment strategies, informed by interviews with 35 clinical, pharmacy, data analytics, and policy leaders from health plans and PBMs across the country.

This is a webinar series hosted by SAMHSA that brings together presentations by several experts on the impact of the opioid crisis on black and Latinx communities and innovative responses tailored to these populations. The website contains recordings of the webinars, powerpoint slides, and helpful culturally competent resources.